Patents by Inventor Sagar A. Vaidya

Sagar A. Vaidya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of mucopolysaccharidosis type I
    Patent number: 11857641
    Abstract: Described herein are methods and compositions for treating MPS I (Hurler/Hurler-Scheie/Scheie Syndrome) by administering to the subject a composition comprising a iduronidase (IDUA) polynucleotide. In one aspect, provided is a method of reducing, delaying and/or eliminating one or more of the need for additional treatment procedures, the onset, progression and/or severity of symptoms in a subject with MPS I, by administering to the subject a composition comprising a iduronidase (IDUA) polynucleotide.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: January 2, 2024
    Assignee: Sangamo Therapeutics, Inc.
    Inventors: Dale Ando, Cheryl Wong Po Foo, Sagar A. Vaidya, Shelley Q. Wang
  • METHODS FOR THE TREATMENT OF BETA-THALASSEMIA
    Publication number: 20230381225
    Abstract: Described herein are methods and compositions for treating a beta-thalassemia.
    Type: Application
    Filed: March 20, 2023
    Publication date: November 30, 2023
    Applicant: SANGAMO THERAPEUTICS, INC.
    Inventors: Weston P. Miller, IV, John Tomaro, Sagar A. Vaidya, Mark Walters
  • METHOD FOR THE TREATMENT OF BETA-THALASSEMIA
    Publication number: 20200316116
    Abstract: Described herein are methods and compositions for treating a beta-thalassemia.
    Type: Application
    Filed: March 31, 2020
    Publication date: October 8, 2020
    Inventors: Weston P. Miller, IV, John Tomaro, Sagar A. Vaidya, Mark Walters
  • METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE I
    Publication number: 20200246486
    Abstract: Described herein are methods and compositions for treating MPS I (Hurler) disease.
    Type: Application
    Filed: August 7, 2019
    Publication date: August 6, 2020
    Inventors: Dale Ando, Cheryl Wong Po Foo, Sagar A. Vaidya, Shelley Q. Wang
  • METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE II
    Publication number: 20200063160
    Abstract: Described herein are methods and compositions for treating MPSII (Hunter) disease.
    Type: Application
    Filed: August 7, 2019
    Publication date: February 27, 2020
    Inventors: Dale Ando, Cheryl Wong Po Foo, Sagar A. Vaidya, Shelley Q. Wang
  • Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses
    Publication number: 20060057104
    Abstract: The present invention provides methods for stimulating Toll-like receptors (TLR) to activate IRF (e.g., an IRF3) and signaling pathway, and thereby directing an antimicrobial activity. The present invention also provides methods for identifying agents that bind and/or stimulate TLR and mediate induction of an IRF3 pathway, thereby directing an antimicrobial activity. Additionally, the invention provides methods and agents for suppressing stimulation of TLR, thereby directing an anti-inflammatory response.
    Type: Application
    Filed: April 24, 2003
    Publication date: March 16, 2006
    Applicant: THE Regents of the University of California Office of the President
    Inventors: Genhong Cheng, Robert Modlin, Sagar Vaidya, Sean Doyle